BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 19, 2017
View Archived Issues
Benitec Biopharma's BB-301 awarded orphan drug status in E.U. for OPMD
Read More
EC grants orphan drug designation to PBI-4050 for Alstrom syndrome
Read More
FDA, EMA accept Boehringer Ingelheim's BI-695501 for review
Read More
FDA grants fast track designation to aTyr Pharma's Resolaris
Read More
Global Blood Therapeutics begins enrollment in phase III study of GBT-440
Read More
Novel TyroSphere formulation of adapalene for topical acne therapy
Read More
Immunomedics presents new data for IMMU-132
Read More
Launch of the Coalition for Epidemic Preparedness Innovations
Read More
Promising results from final phase III trial of Cimzia in chronic plaque psoriasis
Read More
Takeda and Ovid collaborate on TAK-935 for rare pediatric epilepsies
Read More
aTyr Pharma provides overview of ongoing projects
Read More
NIAID initiates phase I trial of VRC07-523LS
Read More
Lilly to acquire CoLucid Pharmaceuticals
Read More
Mallinckrodt reaches agreement with FTC over Synacthen Depot
Read More
WuXi-MedImmune cleared to conduct phase I studies of WBP-216 in China
Read More
Malaria vaccine using genetically engineered Plasmodium falciparum parasites tested in humans
Read More
Exelixis discovers new S1P1 and S1P5 receptor agonists
Read More
SignalChem Lifesciences describes novel carbonic anhydrase 9, 12 inhibtors
Read More
Bioblast Pharma releases results of phase IIa study of trehalose in SCA3 patients
Read More
Academia Sinica discloses new glucagon-like peptide 1 modulators
Read More
Redx Pharma discovers new compounds promoting interferon alpha production
Read More
AstraZeneca presents novel CDK9/cyclin T1 inhibitors
Read More
Matrine derivative YF-18 demonstrates therapeutic potential in models of lung cancer
Read More
FDA awards rare pediatric disease designation to TXA-127 from Tarix Orphan
Read More
HUYA Bioscience enters strategic collaboration with CAS Innovation
Read More
Catabasis describes development, structure and plans for CAT-5571
Read More